Zyla Health, a dynamic health startup based in Gurgaon, has successfully raised $4 million in its Series A funding round, marking a significant milestone in its mission to revolutionize healthcare delivery in India. The funding round was spearheaded by Exfinity Venture Partners and witnessed participation from key investors, including Sony Innovation Fund, Venture Catalysts, and Aureolis led by Paula Mariwala.
This latest injection of capital comes on the heels of Zyla Health’s pre-series A round in July of the previous year, where it secured $1 million from a group of angel investors. Notable institutional backers in the company include Kae Capital, Secocha Ventures, Canara Bank Ventures, and Seeders.
Zyla Health stands out in the health-tech landscape by offering a robust platform dedicated to providing personalized care for individuals grappling with chronic health conditions. The platform, supported by an in-house care team, seamlessly integrates across the healthcare ecosystem through application programming interfaces (APIs), encompassing client data lakes, diagnostic vendors, and smart devices to ensure scalability.
Khushboo Aggarwal, the Founder and CEO of Zyla Health, expressed excitement about the company’s trajectory, stating, “It is a very exciting time at Zyla. We have witnessed 300% year-on-year growth and 100% retention of our key B2B accounts in the last one year. With a fantastic leadership team by our side and the new fuel for growth, we are ready to truly revolutionize healthcare delivery in India.”
The Series A funding will serve as a catalyst for Zyla Health’s ambitious growth plans, focusing on its three core verticals: insurance, corporates, and big pharma. Additionally, the funds will be channeled towards product integrations across the healthcare ecosystem to enhance scalability.
Over the past year, Zyla Health has successfully onboarded new clients, including Max Life Insurance, HDFC Ergo, Pfizer, Zydus, IBM, DHL, Godrej, GEP, and others. The platform’s value proposition lies in its ability to improve the health conditions of high-risk individuals, consequently reducing insurance claims and premiums for corporate clients. Moreover, Zyla Health is dedicated to enhancing medication outcomes and adherence for pharmaceutical drug users.
The successful funding round not only validates Zyla Health’s innovative approach but also positions the company to play a transformative role in the Indian healthcare landscape. The support from investors like Exfinity Venture Partners, Sony Innovation Fund, Venture Catalysts, and Aureolis signifies confidence in Zyla’s ability to drive meaningful innovation in healthcare delivery.
As Zyla Health charts its course with renewed capital, the strategic focus on product integrations within the healthcare ecosystem is a key move. The emphasis on scalability through API integrations with client data lakes, diagnostic vendors, and smart devices positions Zyla as a technology-driven enabler of comprehensive healthcare solutions, aligning with the evolving landscape of healthcare technology.
